v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:              
Net loss $ (18,363,225) $ (7,742,597) $ (6,672,464) $ (32,430,903) $ (26,105,822) $ (39,103,367)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Allowances for credit losses         213,787 200,454  
Loss on extinguishment on vendor obligation         60,120  
Loss on extinguishment of debt 8,881,694     8,881,694  
Loss on contract termination fee         766,394  
Amortization of debt discount         2,343,252 33,411  
Stock-based compensation         2,562,514 28,708,643  
Reserve for inventory obsolescence 55,000       72,967 $ 5,988,257
Depreciation 27,635   39,731   55,497 79,538  
Amortization         657,924 1,526,129  
Changes in operating assets and liabilities:              
Accounts receivable, net         (250,904) 362,911  
Inventories, net         56,336 487,465  
Prepaid and other current assets         (410,010) (65,001)  
Other assets         332  
Accounts payable         2,432,030 3,141,897  
Accrued expenses and other liabilities         2,640,868 1,145,749  
Operating lease liabilities, net         (32,906) (5,720)  
Due from / to related parties, net         (251,068) 61,112  
Net cash used in operating activities         (6,307,328) (3,426,447)  
Cash flows from investing activities:              
Investments in capitalized software         (447,230) (405,059)  
Net cash used in investing activities         (447,230) (405,059)  
Cash flows from financing activities:              
Proceeds from exercise of warrants         1,000  
Proceeds from promissory note         615,000  
Repayment of promissory note         (36,751)  
Repayment of seller promissory note         (137,141)  
Proceeds from term loan         703,366  
Proceeds from revolving line of credit         17,146,000  
Repayment of revolving line of credit         (1,643,923) (18,697,494)  
Proceeds from convertible notes         14,200,000  
Proceeds from merchant cash advance         234,157  
Repayment of merchant cash advance         (89,909)  
Repayment of term loan         (2,104,557)  
Proceeds from common stock issued pursuant to equity purchase agreement         567,722  
Proceeds from common stock issued pursuant to public offering         4,000,000  
Equity issuance costs         (1,157,500) (1,208,498)  
Net cash provided by financing activities         9,168,360 3,223,112  
Net change in cash and cash equivalents         2,413,802 (608,394)  
Cash and cash equivalents at beginning of period   $ 42,571   $ 1,028,336 42,571 1,028,336 1,028,336
Cash and cash equivalents at end of period $ 2,456,373   $ 419,942   2,456,373 419,942 $ 42,571
Supplemental disclosure of cash flow information:              
Cash paid for income taxes          
Cash paid for interest         516,505 1,477,713  
Supplemental disclosure of non-cash investing and financing activities:              
Issuance of common stock and warrants in settlement of accrued compensation         2,599,611  
Issuance of common stock in settlement of vendor and debt obligation         2,001,620  
Fair value of PIPE and placement agent warrants         12,733,596  
Convertible notes issued in lieu of cash for placement agent fee         133,985  
Subscription receivable         581,695  
Issuance of commitment shares under equity purchase agreement         594,320  
Common stock issued in partial settlement of seller’s note         $ 1,500,000